Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schachar

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Genes, Brain, and Behavior|October 3, 2006
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorderK M Dorval, K G Wigg, J Crosbie, et al.
Molecular Psychiatry|September 21, 2005
Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorderN Laurin, V L Misener, J Crosbie, et al.
Molecular Psychiatry|August 10, 2005
The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorderY Feng, J Crosbie, K Wigg, et al.
Molecular Psychiatry|October 22, 2003
Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorderV L Misener, P Luca, O Azeke, et al.
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|November 3, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent PsychiatryR Hamilton, C Gray, S A Bélanger, et al.
The Canadian Journal of Cardiology|November 10, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent PsychiatryA E Warren, R M Hamilton, S A Bélanger, et al.
Paediatrics & Child Health|November 2, 2010
Cardiac risk assessment before the use of stimulant medications in children and youthS A Bélanger, A E Warren, R M Hamilton, et al.
Biological Psychiatry|March 10, 2001
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorderC L Barr, C Xu, J Kroft, et al.
Frontiers in Child and Adolescent Psychiatry|January 22, 2025
Investigating heterogeneity across autism, ADHD, and typical development using measures of cortical thickness, surface area, cortical/subcortical volume, and structural covarianceYounes Sadat-Nejad, Marlee M Vandewouw, R Cardy, et al.
Molecular Psychiatry|November 18, 2015
Psychiatric gene discoveries shape evidence on ADHD's biologyA Thapar, J Martin, E Mick, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Genes, Brain, and Behavior|October 3, 2006
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorderK M Dorval, K G Wigg, J Crosbie, et al.
Molecular Psychiatry|September 21, 2005
Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorderN Laurin, V L Misener, J Crosbie, et al.
Molecular Psychiatry|August 10, 2005
The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorderY Feng, J Crosbie, K Wigg, et al.
Molecular Psychiatry|October 22, 2003
Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorderV L Misener, P Luca, O Azeke, et al.
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|November 3, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent PsychiatryR Hamilton, C Gray, S A Bélanger, et al.
The Canadian Journal of Cardiology|November 10, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent PsychiatryA E Warren, R M Hamilton, S A Bélanger, et al.
Paediatrics & Child Health|November 2, 2010
Cardiac risk assessment before the use of stimulant medications in children and youthS A Bélanger, A E Warren, R M Hamilton, et al.
Biological Psychiatry|March 10, 2001
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorderC L Barr, C Xu, J Kroft, et al.
Frontiers in Child and Adolescent Psychiatry|January 22, 2025
Investigating heterogeneity across autism, ADHD, and typical development using measures of cortical thickness, surface area, cortical/subcortical volume, and structural covarianceYounes Sadat-Nejad, Marlee M Vandewouw, R Cardy, et al.
Molecular Psychiatry|November 18, 2015
Psychiatric gene discoveries shape evidence on ADHD's biologyA Thapar, J Martin, E Mick, et al.
Pageof 7